Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-023400
Filing Date
2025-11-14
Accepted
2025-11-14 16:00:58
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1101555
2 EX-31.1 ex31-1.htm EX-31.1 21244
3 EX-31.2 ex31-2.htm EX-31.2 20676
4 EX-32.1 ex32-1.htm EX-32.1 7086
5 EX-32.2 ex32-2.htm EX-32.2 6734
6 GRAPHIC form10-q_001.jpg GRAPHIC 36681
7 GRAPHIC form10-q_002.jpg GRAPHIC 67769
8 GRAPHIC form10-q_003.jpg GRAPHIC 15061
9 GRAPHIC form10-q_004.jpg GRAPHIC 19218
10 GRAPHIC form10-q_005.jpg GRAPHIC 15158
11 GRAPHIC form10-q_006.jpg GRAPHIC 12348
  Complete submission text file 0001493152-25-023400.txt   6524570

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE gtbp-20250930.xsd EX-101.SCH 49391
13 XBRL CALCULATION FILE gtbp-20250930_cal.xml EX-101.CAL 38949
14 XBRL DEFINITION FILE gtbp-20250930_def.xml EX-101.DEF 233264
15 XBRL LABEL FILE gtbp-20250930_lab.xml EX-101.LAB 429578
16 XBRL PRESENTATION FILE gtbp-20250930_pre.xml EX-101.PRE 347063
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 880421
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 251485498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)